Venlafaxine (Envelaf (75 mg)) is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI), prescribed for depression, generalized anxiety disorder, social anxiety disorder, and panic ...
Venlafaxine (Effexor, Wyeth-Ayerst Laboratories), a serotonin and norepinephrine reuptake inhibitor indicated for major depressive disorder, [4] has been studied for treatment of hot flashes in women ...
Venlafaxine (as HCl) 37.5mg, 75mg, 150mg; ext-rel caps. Effexor XR is supplied in 15-, 30-, and 90-count bottles, and a carton of 10 Redipak blister strips of 10 capsules each. Effexor XR is available ...
Venlafaxine is the first antidepressant 25 mg of effexor acts via inhibiting serotonin and noradrenaline reuptake. A year-old patient with symptoms of insomnia, depression, anhedonia, fatigue admitted ...
Low-dose estradiol and low-dose venlafaxine were both effective and well-tolerated in a trial comparing them with placebo as treatments for vasomotor symptoms (VMS) in peri- and postmenopausal women, ...
Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14 Estrogen withdrawal ...
Hormonal manipulation is used to manage and control prostate cancer. It is useful as adjuvant therapy in early-stage disease and is the foundation for disease and symptom management in advanced ...
Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer's Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone's Venlafaxine HCl 150 Mg Extended-Release Capsules Due to ...
Pfizer Inc. is voluntarily recalling one lot of 30-count Effexor XR (venlafaxine HCl) 150 mg extended-release capsules, one lot of 90-count Effexor XR (venlafaxine HCl) 150 mg extended-release ...
Venlafaxine (Venset (75 mg)) is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI), prescribed for depression, generalized anxiety disorder, social anxiety disorder, and panic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results